GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » 3-Year EPS without NRI Growth Rate

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) 3-Year EPS without NRI Growth Rate : -22.80% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB 3-Year EPS without NRI Growth Rate?

ExpreS2ion Biotech Holding AB's EPS without NRI for the three months ended in Mar. 2024 was kr-0.21.

During the past 3 years, the average EPS without NRI Growth Rate was -22.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of ExpreS2ion Biotech Holding AB was 0.60% per year. The lowest was -41.60% per year. And the median was -8.50% per year.


Competitive Comparison of ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate falls into.



ExpreS2ion Biotech Holding AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


ExpreS2ion Biotech Holding AB  (OSTO:EXPRS2) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


ExpreS2ion Biotech Holding AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Traded in Other Exchanges
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines